Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eagle Capital Growth Fund (GRF)

Eagle Capital Growth Fund (GRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 4,853 K
  • Annual Income, $ 4,612 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 8.04
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.79 +7.25%
on 10/28/24
10.99 -4.46%
on 11/20/24
+0.59 (+5.95%)
since 10/21/24
3-Month
9.42 +11.46%
on 09/03/24
10.99 -4.46%
on 11/20/24
+1.04 (+10.99%)
since 08/21/24
52-Week
7.93 +32.41%
on 11/22/23
10.99 -4.46%
on 11/20/24
+1.86 (+21.53%)
since 11/21/23

Most Recent Stories

More News
Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

/PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived...

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)
Eagle Capital Growth Fund Declares Year-End Distribution of $0.37 Per Share in Cash

The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE American: GRF) today declared a year-end distribution of $0.37 per share in cash. The record date for this distribution is November 18, 2022, and the...

GRF : 10.50 (unch)
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson

Victor Grifols Roura, who devoted 50 years to building Grifols in senior roles including CEO for 30 years, retires as non-executive Chairperson and is...

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

The country, with an increasing immunoglobulin (Ig) usage rate, currently imports about 85% of its Ig demand for patients in Canada who rely on this lifesaving...

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

The country, with an increasing immunoglobulin (Ig) usage rate, currently imports about 85% of its Ig demand for patients in Canada who rely on this lifesaving...

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)
Eagle Capital Growth Fund Declares Year-End Distribution of $0.97 Per Share

The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.97 per share in cash. The record date for this distribution is November 19, 2021, and...

GRF : 10.50 (unch)
Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines

/PRNewswire/ -- Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ:GRFS), one of the world's leading producers of plasma-derived medicines with a more than 110-year track...

GRFS : 8.43 (-1.98%)
GRF : 10.50 (unch)
GigaGen Licenses ProteoNic’s 2G UNicTM Technology Platform for High Yield Production of GigaGen’s Mono- and Polyclonal Antibody Drug Candidates

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- GigaGen Inc. , a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint...

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)
Eagle Capital Growth Fund Elects Anne M. Nichols, CFA as Director; Expands Stock Repurchase Authority

The Board of Directors of Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) at a regular Board meeting today unanimously elected Anne M. Nichols, CFA as a Director.

GRF : 10.50 (unch)
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-2050 for COVID-19

First-in-human study evaluating recombinant hyperimmunes

GRF : 10.50 (unch)
GRFS : 8.43 (-1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

GRF Dividends

Date Value
11/22/23 $0.3500
11/17/22 $0.3700
11/18/21 $0.9700
12/03/20 $0.5500
11/21/19 $0.5600
11/21/18 $0.5300
12/10/14 $0.3700
12/11/13 $1.0200
12/13/12 $0.3600
12/14/11 $1.0500
12/15/10 $0.2800
12/09/09 $0.0500
12/10/08 $0.3512
12/12/07 $0.8765
12/18/06 $0.6865
06/22/06 $0.5000
12/19/05 $0.1648
12/16/04 $0.1956
12/11/03 $0.3482
12/24/02 $0.5412
12/24/01 $0.6445
06/27/01 $0.0280
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar